The science and business of biotechnology.

Nature Biotechnology devotes pages specifically to in-depth analysis of issues concerning biotechnology intellectual property case law and policy, together with breaking news on patents. Also included in each issue are key emerging areas such as computational biology and materials science.

Aims and Scope: Nature Biotechnology is a monthly journal covering the science and business of biotechnology. It publishes applied research of relevance to the biological, biomedical, agricultural and environmental sciences as well as covering the commercial, political, ethical, legal and societal aspects of this research. (biotechmedia.com)

Click Here, Get Nature Biotechnology, Free Subscription

• Qualify for Your Free Subscription!
• Geographic Eligibility: USA, Canada, Selected International
• Publisher: Nature Publishing Group

Visit Nature Biotechnology Website

Nature Biotechnology (Nat Biotechnol; ISSN 1087-0156) is an academic journal covering the science and business of biotechnology.

Nature Biotechnology is a continuation of Bio/technology (Biotechnology (NY); ISSN 0733-222X), which was founded in 1983 and renamed in 1996. It is published monthly by the Nature Publishing Group, a division of Macmillan Publishers Ltd. Like other Nature journals, there is no external Editorial Board; editorial decisions are made by an in-house team, although peer review by external expert referees forms a part of the review process.

Its 2005 impact factor was 22.7, making it the highest cited research journal in the category of biotechnology and applied microbiology, and one of the 20 most highly cited scientific journals. In comparison, the impact factors of general science journals Science and Nature for the same period were 30.927 and 29.273, respectively.

The current editor of Nature Biotechnology is Andrew Marshall. The founding editor of Bio/technology was Christopher Edwards. (Wikipedia.org)